Overview
An Open Dose-finding Study of Oral Applied Hexaminolevulinate (HAL) Imaging in Patients With Suspicion or High Risk of Neoplasia in the Colon
Status:
Terminated
Terminated
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
Participant gender: